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Spinal and bulbar muscular atrophy (SBMA) is an X-linked neuromuscular disease caused by a trinucleotide (CAG) repeat expansion
in the androgen receptor gene. Patients with SBMA have weakness, atrophy, and fasciculations in the bulbar and extremity muscles.
Individuals with CAG repeat lengths greater than 62 have not previously been reported. We evaluated a 29 year old SBMA patient
with 68 CAGs who had unusually early onset and ﬁndings not seen in others with the disease. Analysis of the androgen receptor
gene conﬁrmed the repeat length of 68 CAGs in both peripheral blood and ﬁbroblasts. Evaluation of muscle and sensory function
showed deﬁcits typical of SBMA, and in addition the patient had manifestations of autonomic dysfunction and abnormal sexual
development. These ﬁndings extend the known phenotype associated with SBMA and shed new insight into the eﬀects of the
mutated androgen receptor.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
3.0/).
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Spinal and bulbar muscular atrophy (SBMA), also
known as Kennedy’s disease [1], is an X-linked
neuromuscular disease caused by a CAG repeat
expansion in the androgen receptor gene. Aﬀected males
develop weakness, atrophy, and fasciculations in the limbhttp://dx.doi.org/10.1016/j.nmd.2014.06.441
0960-8966/Published by Elsevier B.V.
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motor eﬀects, degeneration of the dorsal root ganglia can
result in a loss of sensory function in the distal
extremities. Patients also often show evidence of
androgen insensitivity, such as gynecomastia,
oligospermia, and erectile dysfunction.
The disease manifestations likely result from a toxic gain
of function of the androgen receptor that is dependent on
ligand (testosterone and dihydrotestosterone) [2].
However, loss of normal receptor function also occurs,
and contributes to the androgen insensitivity. The mutantcommons.org/licenses/by-nc-nd/3.0/).
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intracellular inclusions in susceptible cells [3,4]. The
principal cellular disturbance caused by the mutant AR is
likely transcriptional dysregulation, with secondary
changes occurring in cell signaling, mitochondrial
activity, and axonal transport [5–8].
Neurological symptoms typically develop during the
fourth or ﬁfth decade of life, but the onset ranges from
ages 18 to 64 [9]. The length of the CAG repeat in the
AR gene correlates inversely with the age of disease
onset, with longer repeats associated with earlier onset
[10]. The disease has been reported with repeat lengths
between 38 and 62 CAGs [8,10].
Here we report a 29 year old patient with SBMA who
has a 68 CAG repeat expansion in the androgen receptor
gene. This patient not only had early onset of disease,
but also was found to have additional ﬁndings of
autonomic dysfunction and abnormal sexual development.
2. Case report
We report a 29-year-old male of Afro-Caribbean
ancestry who has had muscle weakness in his thighs,
fatigue after exercise, fasciculations, cramping, and
tremor since age 18. He has also had burning
neuropathic pain with dysesthesia in the distal lower
extremities for the past two years. He occasionally takes
ibuprofen to alleviate the pain in his feet. Over the past
several months he has also experienced similar symptoms
in his ﬁngertips. His feet usually feel cool, and he
reported decreased sweating. He has no diﬃculty with
swallowing, however he does experience fatigue in the
muscles of mastication after a meal. He occasionally
experiences phlegm accumulating in his throat, although
he does not report choking. In addition to the
neurological features, he had a congenital abnormality of
the penis (chordee), which was surgically corrected at age
7. He also has bilateral testicular atrophy and diﬃculties
with ejaculation. By age 16 he developed gynecomastia,
which became socially stigmatizing. He reported having
decreased facial hair growth overall and only occasionally
shaves two areas on his upper lip. He has a pertinent
family history of a 19 year old maternal ﬁrst cousin
once-removed with exercise intolerance and no other
symptoms who has not received genetic testing. He also
had a maternal great grandfather without a diagnosis
who had decreased mobility. His mother passed away at
age 40, and did not have any neuromuscular symptoms.
On examination the patient had pronounced
gynecomastia bilaterally. Fibrillations and atrophy were
noted in the tongue, and weakness was observed in the
orbicularis oculi and orbicularis oris. He had prominent
perioral fasciculations. Limb weakness was severe in the
shoulders, thighs, and toes bilaterally. Sensory testing
showed a loss of temperature and vibratory sensation in
the ﬁngers and toes with a length-dependent gradient. On
gait testing, he had diﬃculty standing on his heels andankles. Abnormalities were also found in quantitative
muscle strength testing (Fig. 1A) [11] and muscle MRI
(Fig. 1B and C), demonstrating the extent of disease
involvement at a relatively early age.
An evaluation of autonomic function showed evidence
of sudomotor dysfunction, as negligible sweat responses
(less than 40 nL total each site) were detected at the
forearm, calf, ankle, and foot. Tilt table testing showed
evidence of orthostatic tachycardia, with the heart rate
increasing by 35–40 beats per minute with prolonged
upright position in the absence of orthostatic blood
pressure changes or symptoms. No abnormalities were
detected in valsava testing, heart rate during deep
breathing and quantitative sensory testing of vibration
and cool detection thresholds. Skin biopsies were
performed in the distal leg (10 cm proximal to the lateral
malleolus), distal thigh, and proximal thigh, and showed
a normal epidermal nerve ﬁber (ENF) density compared
to controls [12]. ENF density at the distal leg was
24.3 ﬁbers/mm. Laboratory tests, including TSH, vitamin
B12, anti-nuclear antibodies, fasting glucose, and
hemoglobin A1c were normal. Electrocardiography was
normal on two separate evaluations.
2.1. Detection of a 68 CAG repeat expansion in the androgen
receptor
Sequencing and PCR analysis of genomic DNA isolated
from the patient’s venous blood and forearm skin
ﬁbroblasts showed a repeat length of 68 CAGs in both
samples. CAG repeat length was conﬁrmed by clinical
testing (Athena Diagnostics) of peripheral blood, and
remained unchanged with repeated testing after one year.
Fig. 2A shows a DNA fragment obtained by PCR with
primers ﬂanking the CAG repeat run on a 20%
acrylamide gel with a DNA fragment obtained from
another patient with 62 CAGs. Sequencing of the
remaining translated portion of the androgen receptor
gene was done, and no other genetic variants were found.
In particular, the glycine repeat length was in the normal
range [13]. Androgen receptor protein levels in
patient-derived ﬁbroblasts were comparable to control
samples with non-expanded androgen receptor (Fig. 2B).
3. Discussion
Patients with SBMA usually present with the onset of
weakness in their mid-forties and have an average
androgen receptor repeat length of 47 CAGs [9]. Here we
describe a patient with a 68 CAG repeat who had onset
of weakness at age 18 and additional features of disease
which have not previously been reported, including
abnormalities in sexual development and sudomotor
function. The identiﬁcation of a patient with 68 CAGs
expands the spectrum of disease features associated with
SBMA, as the disease has previously been reported only
in patients with 62 CAGs or less.
Fig. 1. Strength testing and muscle MRI ﬁndings. Quantitative muscle strength testing in 12 diﬀerent muscle groups shows the degree of muscle weakness
(in kg) as compared to healthy controls matched for age, height, weight, and body side (A). STIR MRI image of the right thigh showing patchy areas of
hyperintensity indicative of muscle injury and degeneration (B). T1 image of the same region shows muscle atrophy and evidence of increased fat signal
within the muscle (C).
Fig. 2. Androgen receptor gene and protein. PCR products from patient
DNA were generated using primers that bracket the CAG expansion.
Acrylamide gel electrophoresis shows the band shift relative to a 62 CAG
sample from a diﬀerent patient (A). Androgen receptor expression is equal
in patient derived ﬁbroblast cultures when compared to control samples
on western blotting. Dihydrotestosterone (DHT) treatment results in
similar upregulation of androgen receptor levels in all samples evaluated
(B).
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the androgen receptor with a chordee deformity is novel
but not unexpected, given the known expression of
androgen receptor in sexually dimorphic tissues. Features
of androgen insensitivity including infertility,
gynecomastia, and reduced androgenic alopecia [14] havebeen described in SBMA. It is possible that the
additional ﬁndings of chordee and autonomic
involvement observed in this patient are due to the larger
expansion of the polyglutamine repeat. Ogata et al. [15]
reported the identiﬁcation of a 44 CAG repeat in
the androgen receptor of an 11 year old boy with
under-masculinized genitalia and chordee without
neuromuscular disease. The diagnosis of 5a-reductase
deﬁciency has also been reported in a pediatric male
patient with chordee and normal androgen receptor
studies [16]. Treatment of this infant with
dihydrotestosterone and surgical release of chordee
resulted in improvement of symptoms.
Although ﬁndings of sensory neuropathy are typical in
SBMA, the ﬁndings suggestive of small nerve ﬁber
involvement seen in this subject have not been described
in the disease. Previous studies have found axonal
atrophy of large myelinated sensory ﬁbers [17], and in a
cohort of 54 SBMA subjects sensory nerve action
potentials (SNAP) were reduced in at least 94% of
subjects [9]. A study of small ﬁber involvement in two
C. Grunseich et al. /Neuromuscular Disorders 24 (2014) 978–981 981SBMA subjects found a reduction of epidermal nerve ﬁber
density and evidence of autonomic skin denervation on
skin biopsy [18]. These ﬁndings likely represent
subclinical involvement of small diameter peripheral
nerves. Subclinical involvement of the autonomic system
has been demonstrated in four out of ﬁve subjects with
SBMA previously [19]. Plasma levels of noradrenaline
were found to be reduced in these patients, which also
implies dysfunction of the sympathetic nervous system.
Our patient has abnormal sudomotor function and
complaints of anhidrosis, suggesting abnormal
sympathetic post-ganglionic activity. In addition, the
presence of orthostatic tachycardia suggests dysfunction
of the small ﬁber sympathetic nervous system [20].
Altogether the presentation of pain in the distal
extremities with abnormal post-ganglionic sympathetic
activity suggests that small, unmyelinated nerve ﬁbers are
dysfunctional in this patient. The lack of a reduction in
the epidermal nerve ﬁber density may be due to the
relatively recent onset of his pain, or evidence of
unmyelinated nerve dysfunction without degeneration.
The normal ENF ﬁnding may also be related to the
sampling location, as the biopsy site was proximal
to the distal extremities where the pain was described. A
normal ENF density has also been reported with
chemotherapy-induced neuropathy in patients who were
experiencing neuropathic pain [21].
Collectively, these ﬁndings emphasize that the CAG
repeat expansion in the androgen receptor gene is capable
of altering androgen-dependent signaling pathways. Our
observations suggest that the CAG expansion mutation
may result in dysfunction of unmyelinated nerve ﬁbers
and adversely aﬀect sexual development.
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